Dishman Carbogen Amcis Limited Share Price

Equities

DCAL

INE385W01011

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:52 24/05/2024 pm IST 5-day change 1st Jan Change
188.5 INR -2.51% Intraday chart for Dishman Carbogen Amcis Limited -2.56% +10.27%
Sales 2022 2.14TCr 26Cr Sales 2023 2.41TCr 29Cr Capitalization 1.96TCr 24Cr
Net income 2022 18Cr 21.68L Net income 2023 -30Cr -35.89L EV / Sales 2022 2.02 x
Net Debt 2022 1.43TCr 17Cr Net Debt 2023 1.9TCr 23Cr EV / Sales 2023 1.6 x
P/E ratio 2022
161 x
P/E ratio 2023
-65.6 x
Employees 1,295
Yield 2022 *
-
Yield 2023
-
Free-Float 29.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.51%
1 week-2.56%
Current month-18.80%
1 month-19.25%
3 months-23.19%
6 months+11.37%
Current year+10.27%
More quotes
1 week
187.40
Extreme 187.4
196.95
1 month
187.40
Extreme 187.4
244.80
Current year
179.00
Extreme 179
283.00
1 year
113.30
Extreme 113.3
283.00
3 years
80.00
Extreme 80
283.00
5 years
46.05
Extreme 46.05
283.00
10 years
46.05
Extreme 46.05
396.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 38 07/12/07
Director of Finance/CFO 42 -
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 73 17/07/17
Director/Board Member 73 17/17/17
Director/Board Member 76 17/17/17
More insiders
Date Price Change Volume
24/24/24 188.5 -2.51% 501,357
23/24/23 193.4 +0.62% 427,198
22/24/22 192.2 -1.44% 362,239
21/24/21 195 -0.84% 369,975
18/24/18 196.6 +1.63% 120,421

Delayed Quote NSE India S.E., May 24, 2024 at 05:13 pm IST

More quotes
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Company’s segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.
More about the company

Quarterly revenue - Rate of surprise